Cremaschi G, Genaro A M, Sterin-Borda L
Centro de Estudios Farmacológicos y de Principios Naturales, CONICET, Buenos Aires, Argentina.
Mol Immunol. 1989 Jul;26(7):601-9. doi: 10.1016/0161-5890(89)90042-4.
Previously we have demonstrated a molecular relationship between H-2 class I antigens and beta adrenoceptors from cardiac tissue. Here we show this type of interaction taking place with beta adrenoceptors from splenic cells and their purified membranes and the participation of cytoskeletal proteins in the phenomenon. Alloimmune, as well as anti-class I but not anti-class II, antibodies were able to inhibit in a competitive manner the binding of (-)-[3H]dihydroalprenolol to splenic lymphocytes and their purified membranes, and to increase cyclic AMP levels in intact cells as a consequence of beta adrenoceptor activation. Furthermore, colchicine (a microtubule disrupting drug), but not cytochalasin B (a microfilament disrupting drug), was able to abrogate alloimmune antibody inhibition over the beta radioligand binding to its receptor on both intact splenocytes and their membranes. Alloantibody actions were significantly diminished by peripheral protein solubilization in purified spleen cell membranes. These data pointed indirectly to the participation of a colchicine binding protein in class I antigen hormone-receptor associations.
此前我们已经证明了心脏组织中H-2 I类抗原与β肾上腺素能受体之间的分子关系。在此我们展示了这种相互作用发生在脾细胞及其纯化膜中的β肾上腺素能受体上,以及细胞骨架蛋白在该现象中的参与。同种免疫抗体以及抗I类而非抗II类抗体能够以竞争性方式抑制(-)-[³H]二氢阿普洛尔与脾淋巴细胞及其纯化膜的结合,并由于β肾上腺素能受体激活而增加完整细胞中的环磷酸腺苷水平。此外,秋水仙碱(一种破坏微管的药物)而非细胞松弛素B(一种破坏微丝的药物)能够消除同种免疫抗体对β放射性配体与其在完整脾细胞及其膜上受体结合的抑制作用。纯化脾细胞膜中的外周蛋白溶解显著减弱了同种抗体的作用。这些数据间接表明了一种秋水仙碱结合蛋白参与了I类抗原-激素受体的结合。